相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
Christopher L. Nobles et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8+ T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency Reversal
Talia M. Mota et al.
JOURNAL OF VIROLOGY (2020)
Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells
Julia Bergild McBrien et al.
NATURE (2020)
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
Christopher C. Nixon et al.
NATURE (2020)
HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells
Yetao Wang et al.
NATURE IMMUNOLOGY (2020)
Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target
Runxia Liu et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy
Kevin B. Einkauf et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion
Marilia Rita Pinzone et al.
NATURE COMMUNICATIONS (2019)
The Activation State of CD4 T Cells Alters Cellular Peptidase Activities, HIV Antigen Processing, and MHC Class I Presentation in a Sequence-Dependent Manner
Julie Boucau et al.
JOURNAL OF IMMUNOLOGY (2019)
Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial
Mark C. Genovese et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
HIV Rebound Is Predominantly Fueled by Genetically Identical Viral Expansions from Diverse Reservoirs
Marie-Angelique De Scheerder et al.
CELL HOST & MICROBE (2019)
Genome-Wide Analysis of Heterogeneous Nuclear Ribonucleoprotein (hnRNP) Binding to HIV-1 RNA Reveals a Key Role for hnRNP H1 in Alternative Viral mRNA Splicing
Sebla B. Kutluay et al.
JOURNAL OF VIROLOGY (2019)
BUD13 Promotes a Type I Interferon Response by Countering Intron Retention in Irf7
Luke Frankiw et al.
MOLECULAR CELL (2019)
Vpr Targets TET2 for Degradation by CRL4(VprBP) E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication
Lei Lv et al.
MOLECULAR CELL (2018)
HIV latency in isolated patient CD4(+) T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing
Steven A. Yukl et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
DDX41 Recognizes RNA/DNA Retroviral Reverse Transcripts and Is Critical for In Vivo Control of Murine Leukemia Virus Infection
Spyridon Stavrou et al.
MBIO (2018)
Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir
Biswajit Das et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
HIV-1 intron-containing RNA expression induces innate immune activation and T cell dysfunction
Hisashi Akiyama et al.
NATURE COMMUNICATIONS (2018)
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial
Desiree van der Heijde et al.
LANCET (2018)
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial
Philip Mease et al.
LANCET (2018)
Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines
Sean Matthew McCauley et al.
Nature Communications (2018)
Improved assays to measure and characterize the inducible HIV reservoir
Marta Massanella et al.
EBIOMEDICINE (2018)
Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity
Alyssa R. Martin et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
Severine Vermeire et al.
LANCET (2017)
HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells
Daniela Cesana et al.
NATURE COMMUNICATIONS (2017)
Digoxin reveals a functional connection between HIV-1 integration preference and T-cell activation
Alexander Zhyvoloup et al.
PLOS PATHOGENS (2017)
Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy
Christine M. Fennessey et al.
PLOS PATHOGENS (2017)
Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors
Christina Gavegnano et al.
PLOS PATHOGENS (2017)
Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Filgotinib, a Selective JAK-1 Inhibitor, After Short-Term Treatment of Rheumatoid Arthritis: Results of Two Randomized Phase IIa Trials
Frederic Vanhoutte et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Anti-proliferative therapy for HIV cure: a compound interest approach
Daniel B. Reeves et al.
SCIENTIFIC REPORTS (2017)
Screening of an FDA-approved compound library identifies levosimendan as a novel anti-HIV-1 agent that inhibits viral transcription
Tsuyoshi Hayashi et al.
ANTIVIRAL RESEARCH (2017)
SMYD2-Mediated Histone Methylation Contributes to HIV-1 Latency
Daniela Boehm et al.
CELL HOST & MICROBE (2017)
Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape
Ross A. Pollack et al.
CELL HOST & MICROBE (2017)
IRFinder: assessing the impact of intron retention on mammalian gene expression
Robert Middleton et al.
GENOME BIOLOGY (2017)
Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy
Mary F. Kearney et al.
JOURNAL OF VIROLOGY (2016)
Disease drivers of aging
Richard J. Hodes et al.
ANNALS REPORTS, VOL 1386 (2016)
The mTOR Complex Controls HIV Latency
Emilie Besnard et al.
CELL HOST & MICROBE (2016)
Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells
Benoit Lacombe et al.
JOURNAL OF VIROLOGY (2016)
Global intron retention mediated gene regulation during CD4+ T cell activation
Ting Ni et al.
NUCLEIC ACIDS RESEARCH (2016)
Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission
Mykola Pinkevych et al.
PLoS Pathogens (2016)
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells
Gianluigi Lichinchi et al.
NATURE MICROBIOLOGY (2016)
CDK11 in TREX/THOC Regulates HIV mRNA 3′ End Processing
Vladimir Pak et al.
CELL HOST & MICROBE (2015)
Gene activity in primary T cells infected with HIV89.6: intron retention and induction of genomic repeats
Scott Sherrill-Mix et al.
RETROVIROLOGY (2015)
BRCA1 functions as a novel transcriptional cofactor in HIV-1 infection
Irene Guendel et al.
VIROLOGY JOURNAL (2015)
Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1
Daniel I. S. Rosenbloom et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus Reactivation In Vitro
Christina Gavegnano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Causal analysis approaches in Ingenuity Pathway Analysis
Andreas Kraemer et al.
BIOINFORMATICS (2014)
Widespread intron retention in mammals functionally tunes transcriptomes
Ulrich Braunschweig et al.
GENOME RESEARCH (2014)
A novel cell-based high-throughput screen for inhibitors of HIV-1 gene expression and budding identifies the cardiac glycosides
Gregory M. Laird et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Cell Cycle Control and HIV-1 Susceptibility Are Linked by CDK6-Dependent CDK2 Phosphorylation of SAMHD1 in Myeloid and Lymphoid Cells
Eduardo Pauls et al.
JOURNAL OF IMMUNOLOGY (2014)
New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
C. Korin Bullen et al.
NATURE MEDICINE (2014)
Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection
Kirston M. Barton et al.
PLOS ONE (2014)
Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
F. Maldarelli et al.
SCIENCE (2014)
Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing
Datsen George Wei et al.
PLOS PATHOGENS (2014)
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Thomas A. Rasmussen et al.
LANCET HIV (2014)
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
Ya-Chi Ho et al.
CELL (2013)
Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)-Expressing CD4+ T cells
Hiroyu Hatano et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A Novel PCR Assay for Quantification of HIV-1 RNA
Liang Shan et al.
JOURNAL OF VIROLOGY (2013)
UPF1 Is Crucial for the Infectivity of Human Immunodeficiency Virus Type 1 Progeny Virions
Anna Kristina P. Serquina et al.
JOURNAL OF VIROLOGY (2013)
RNA splicing regulates the temporal order of TNF-induced gene expression
Shengli Hao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Digoxin Suppresses HIV-1 Replication by Altering Viral RNA Processing
Raymond W. Wong et al.
PLOS PATHOGENS (2013)
Immunologic Basis of Cardiovascular Disease in HIV-Infected Adults
Priscilla Y. Hsue et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
Reactivation of Latent HIV-1 by Inhibition of BRD4
Jian Zhu et al.
CELL REPORTS (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy
Raymond Wong et al.
RETROVIROLOGY (2011)
Histone deacetylase inhibitors and HIV latency
David M. Margolis
CURRENT OPINION IN HIV AND AIDS (2011)
Establishment of HIV Latency in Primary CD4+ Cells Is due to Epigenetic Transcriptional Silencing and P-TEFb Restriction
Mudit Tyagi et al.
JOURNAL OF VIROLOGY (2010)
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
Daniele Merico et al.
PLOS ONE (2010)
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation
Hung-Chih Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 Expression
Kara S. Keedy et al.
JOURNAL OF VIROLOGY (2009)
Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation
Hung-Chih Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Recruitment of a SAP18-HDAC1 Complex into HIV-1 Virions and Its Requirement for Viral Replication
Masha Sorin et al.
PLOS PATHOGENS (2009)
Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
Steven E. Kauder et al.
PLOS PATHOGENS (2009)
The Iws1:Spt6:CTD complex controls cotranscriptional mRNA biosynthesis and HYPB/Setd2-mediated histone H3K36 methylation
Sunnie M. Yoh et al.
GENES & DEVELOPMENT (2008)
Relationship between T cell activation and CD4(+) T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Unexpected roles for UPF1 in HIV-1 RNA metabolism and translation
Lara Ajamian et al.
RNA (2008)
HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription
Xavier Contreras et al.
PLOS PATHOGENS (2007)
Phosphorylation of HIV-I Tat by CDK2 in HIV-I transcription
Tatyana Ammosova et al.
RETROVIROLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity
LS Weinberger et al.
CELL (2005)
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection
PY Hsue et al.
CIRCULATION (2004)
Resting CD4+ T cells from human immunodeficiency virus type I (HIV-1)-infected individuals carry integrated HIV-1 Genomes within actively transcribed host genes
YF Han et al.
JOURNAL OF VIROLOGY (2004)
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma
S Palmer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
PW Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export
D Daelemans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
HIV-1 integration in the human genome favors active genes and local hotspots
ARW Schröder et al.
CELL (2002)
Effects of prostratin on T-cell activation and human immunodeficiency virus latency
YD Korin et al.
JOURNAL OF VIROLOGY (2002)
DNA topoisomerase IIa is required for RNA polymerase II transcription on chromatin templates
N Mondal et al.
NATURE (2001)
Activation of human immunodeficiency virus transcription in T cells revisited:: NF-κB p65 stimulates transcriptional elongation
MJ West et al.
JOURNAL OF VIROLOGY (2001)
Flavopiridol inhibits P-TEFb and blocks HIV-1 replication
SH Chao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1
JJ Coull et al.
JOURNAL OF VIROLOGY (2000)
Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo
AG Chapuis et al.
NATURE MEDICINE (2000)